Legal Disclaimer

By using this Web Site you agree to the following terms and conditions. Please read these terms and conditions carefully. By accessing this Web Site you are deemed to have read and accepted these terms and conditions and it is your responsibility to be aware of, and to observe, the applicable laws and regulations of any relevant jurisdiction. Bregal Capital reserves the right to modify these terms and conditions at any time.


General Disclaimer

The information on this Web Site, including information on web sites referred to via hyperlinks, is for general information purposes only. It should not be relied on for any specific purpose and no representation or warranty is given as regards its accuracy or completeness.

Bregal Capital does not supply any products or services to customers. Nothing contained in this Web Site is an investment advertisement or financial promotion nor does any statement in this site constitute investment advice. Furthermore, no information on this Web Site constitutes investment, tax, legal or any other advice and nothing on this Web Site is intended to constitute an invitation or inducement to engage in investment activity in any jurisdiction.

Neither Bregal Capital nor any affiliates nor their respective officers, employees, agents or sub-contractors shall be liable to you or any other party for any losses or damages which may arise from the access of or reliance on information contained in this Web Site or on information contained in external internet sites that link to this Web Site or which are linked from it. Nothing on this Web Site or in these terms and conditions shall exclude or limit any duty or liability to the extent that such exclusion or limitation is not permissible under applicable law or regulation.


Use of this Web Site

Any use of this Web Site which may disturb the use by other visitors of the internet, which potentially affects the functioning of this Web Site negatively, or which can cause damage to the information provided via this Web Site and/or to the underlying software, is prohibited.



All contents of this Web Site including, but not limited to the text, graphics, links and sounds are the copyright of Bregal Capital. You are permitted to read, download and make copies of the content for non-commercial personal use. All other use and copying of any of the contents of this site, whether directly or by means of a hypertext link, is prohibited unless the prior written consent of Bregal Capital is obtained.



Marks and logos displayed on this Web Site (unless otherwise stated) are the intellectual property rights held by Bregal Capital, its affiliates or their respective investee companies. No permission or licence is granted to use any trademark, service mark, or any other intellectual property rights without the prior written consent of the respective intellectual property right owner.


Change of Information

Bregal Capital reserves the right in its discretion to change without prior warning or notice any information or material contained on this Web Site and the terms and conditions under which this Web Site is used.


Governing Law

On behalf of Bregal Capital, this Web Site is controlled and maintained from London by Bregal Capital. Bregal Capital makes no representation that the material and information is appropriate or available for use in other locations/jurisdictions. These terms and conditions are governed by the laws of England & Wales and any dispute shall be subject to the non-exclusive jurisdiction of the competent Courts of England & Wales.

Authorised and regulated by the Financial Conduct Authority

Opto Circuits India Management Call swiss replica watches It a pleasure to present to you minutes of our extensive discussion with Opto Circuits Management. Mr Vinod Ramnani MD, Mr Bodapeti Bhaskar omega replica CFO, and Mr. Valiveti Bhaskar Dir Operations, participated in this free-wheeling discussion over almost hublot replica 3 hours. MRI+multi-parameter monitor and OEM manufacturing deals-just announceda) Some of these off-the-record developments discussed last time, cartier replica have panned out. Can you tell us more about the deal? What is unique about this deal/product Opto Circuits has signed omega replica a strategic long term agreement with a European manufacturer and distributor replica watches uk of medical equipment. The agreement involves the supply of private label patient monitoring systems by us to rolex replica the partner integrating Criticare modular anesthetic gas delivery products (in their product) for several key markets replica watches, both in the United States and Europe. This should be a significant driver of revenue growth? What will be the near-term cartier replica and medium-term impact? What kind of margins can we expect here? Opto Circuits retains the rights for the Indian market. rolex replica This is a strategic long term deal louis vuitton replica with the manufacturer. This deal replica handbags means that we are assured of some bulk quantities and do not have to go through the distribution route ourselves. chanel replica The margins we will be thinner, but we are spared the higher working capital requirements for omega replica the same, which as you know can be considerable with longer credit cycles for distributors. Is this rolex replica a game changer, will it lead to more pure OEM deals?